Article
A three lncRNA set: AC009975.1, POTEH-AS1 and AL390243.1 as nodal efficacy biomarker of neoadjuvant therapy for HER-2 positive breast cancer
2021-09-21
Abstract excerpt
<title>Abstract</title> <p>Background and purpose LncRNAs have been found to play regulatory role in the chemoresistance after neoadjuvant therapy (NAT) of breast cancers. The breast pathological complete response (pCR) was different from the axillary nodal pCR (apCR) after NAT. And this difference was most significant in HER-2 positive (HER2+) subtype. The aim was to explore whether lncRNA expression in primary...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- da7fff42-a2f2-5195-9ba3-2997761c3c45
- DOI
- 10.21203/rs.3.rs-892533/v1
